Login
From:
Fragile X News Today
(Uncensored)
subscribe
Potential Fragile X Therapy BPN14770 Receives FDA Orphan Drug Status
https://fragilexnewstoday.com/news/fda-grants-bpn14770-orphan-drug-status-fragile-x-syndrome/
links
backlinks
Tagged with:
fda
bpn14770
pde4d
investigational therapy
orphan drug designation
tetra discovery partners
Investigational therapy BPN14770 has been granted orphan drug status by the U.S. Food and Drug Administration for the treatment of fragile X syndrome.
Roast topics
Find topics
Find it!
